AJSM signin
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
First published on August 16, 2007, doi:10.1177/0363546507305010
This version was published on November 1, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/11/1817    most recent
0363546507305010v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lightfoot, A.
Right arrow Articles by Amendola, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lightfoot, A.
Right arrow Articles by Amendola, A.
Related Collections
Right arrow Chondral/cartilage
Right arrow Knee
The American Journal of Sports Medicine 35:1817-1823 (2007)
© 2007 American Orthopaedic Society for Sports Medicine

Winner of the Cabaud Award

Fluorescent Viability Stains Overestimate Chondrocyte Viability in Osteoarticular Allografts

Andrew Lightfoot, MD, James Martin, PhD and Annunziato Amendola, MD*

From the University of Iowa Sports Medicine Center, Orthopaedic Biology Laboratory, Department of Orthopaedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa

* Address correspondence to Annunziato Amendola, MD, UI Sports Medicine Center, Department of Orthopaedics and Rehabilitation, University of Iowa Hospitals and Clinics, 200 Hawkins Drive 01018JPP, Iowa City, IA 52242 (e-mail: ned-amendola{at}uiowa.edu).

Background: Allografts from many tissue banks are carefully processed and stored with the goal of preserving chondrocyte viability. However, the importance of living chondrocytes for graft stability is unclear, in part because actual viabilities of individual allografts at the time of placement are seldom known.

Hypotheses: Cell yields from allograft and fresh cartilage differ significantly if chondrocyte viability in allografts is lower than indicated by fluorescence staining with conventional viability probes. In addition, transmission electron microscopy will show significant differences in the percentage of morphologically abnormal chondrocytes in allograft and fresh cartilage.

Study Design: Controlled laboratory study.

Methods: Fluorescence viability staining, chondrocyte yield, and chondrocyte characteristics were studied in 8 commercial osteochondral allografts (7 hemicondyles, 1 talus) and 4 freshly harvested cartilage samples from an adult distal femur (age, 46 years), from an adult talus (age, 51 years), and from an adult tibial plateau (age, 29 years) and from a juvenile distal tibia (age, 9 years). Selected fresh and allograft specimens were repeatedly frozen and thawed to deliberately kill chondrocytes by membrane disruption. The findings were analyzed to determine if allograft and fresh cartilage were significantly different with respect to each of the 3 different outcome measures.

Results: Although fluorescent staining indicated that approximately 75% of chondrocytes were viable (calcein AM–labeled) in allograft cartilage, counterstaining with 4,'6-diamidino-2-phenylindole showed that fewer than 30% contained identifiable nuclei. In contrast, 100% of cells labeled as viable contained nuclei in fresh cartilage. Killing chondrocytes by freeze-thawing before staining did not diminish calcein AM staining in allograft cartilage but caused a significant reduction in fresh cartilage. The average yield of chondrocytes from allograft cartilage was less than 200 000/100 mg tissue, significantly lower than in fresh cartilage, which averaged more than 1.5 million/100 mg tissue. The yield from freeze-thawed controls was less than 24 000/100 mg. Cell numbers increased after 7 days of culture in all cases except for chondrocytes from freeze-thawed cartilage, an indication that the isolated cells were viable. Morphologic analysis by transmission electron microscopy revealed significant increases in the numbers of chondrocytes with pyknotic or absent nuclei or with disintegrated plasma membranes in allograft versus fresh cartilage.

Conclusion: Conventional fluorescence probes are unreliable for analyzing chondrocyte viability in osteoarticular allografts. Alternative methods for assessment of viability, such as cell culture and ultrastructural imaging, may provide more accurate assessment of viability in allografts.

Clinical Relevance: Conventional staining methods that overestimate chondrocyte viability in osteoarticular allografts may mislead investigators attempting to assess the effects of chondrocyte viability on graft stability following implantation. A more reliable means to measure chondrocyte viability will be required to accurately assess these effects.

Key Words: allograft • cartilage • chondrocyte • viability






HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Orthopaedic Society for Sports Medicine.